Eye Health Ingredients Market Size By Source (Natural, Synthetic), By Ingredient (Lutein, Zeaxanthin, Beta Carotene, Vitamin A, Bilberry Extracts), By Form (Soft gel, capsule & tablets, Liquid, Powder), By End Use (Human, Animal), By Disease Indication (Age related Macular Degeneration, Cataract, Dry Eye Syndrome), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Italy, Spain, Poland, Russia, Netherland, China, India, Japan, Indonesia, Thailand, Australia, South Korea, Malaysia, Singapore, Brazil, Argentina, Saudi Arabia, UAE, South Africa), Application Potential, Price Trend, Competitive Market Share & Forecast, 2017 - 2024

Eye Health Ingredients Market size is projected to exceed USD 290 million by 2024; according to a new research report. 

Rising diseases including age-related macular degeneration (AMD), diabetic retinopathy, glaucoma and cataracts will propel product demand. Protection from UV radiation, elimination of free radicals and enhancing strong vision are other key features stimulating the industry growth. 

Zeaxanthin and Lutein are the broadly used eye care ingredients, high efficiency and effectiveness in lower dosages causes low zeaxanthin consumption compared to lutein. Lutein will witness CAGR exceeding 6.5% up to 2024. Rising demand for infant supplementary to overcome vision deficiency among children are the main factors driving lutein demand.

Bilberry extracts will be worth over USD 25 million by 2024. Potential application outlook in healthcare industry to treat vision disorders will enhance the product penetration. Retinal health enhancement and blood sugar level maintenance are the key substantial benefits. 

Demand for animal eye health ingredients market will witness over 7% growth up to 2024. Preventive care among owners of pet and commercial animal will remain a key driving factor for the segment. 

Shifting consumer preference towards naturally sourced products will drive the industry growth. Synthetic eye health ingredients market is driven by low processing costs with high benefits which will impact natural eye health ingredients market price trend. 

High surgery costs are the factors influencing consumers toward OTC supplements to avoid substantial costs on clinical treatments. Development and innovation in terms of product personalization and customization will be a key strategy for the nutraceutical industry. 

Capsule, soft gel & tablets accounted for more than 40% of the industry share in 2016. Reduced side effects along with ease in consumption are the factors positively influencing the product penetration. 

Age related macular degeneration treatment is the leading segment for the product consumption. Rising dry eye syndrome diseases globally is another factor fueling the eye health ingredients market. 

U.S. eye health ingredients market could witness over 5% growth through to 2024. Growing consumer health consciousness coupled with increasing product launches will drive the regional demand. Low vision and blindness is observed in over 3.2 million people in the North America in 2015, which is estimated to surpass 6 million by 2024. 

Europe, led by Germany and UK will witness growth over 5.5%. High geriatric population along with increasing consumer spending on healthcare will propel the regional industry growth. 

China and India together will witness CAGR over 6.5% up to 2024. Increase in consumer purchasing power along with growing consumer interest for a healthy lifestyle will stimulate industry growth. 

Global industry share is fragmented with large number of manufacturers including Allied Biotech, FMC Corporation, DSM and BASF. MacuShield, Alcon, Amway, Bausch & Lomb, Efamol, Solgar and Swanson are the major customers. Technological advancement and product innovations have led manufacturers to launch gummies for vision enhancement. 

Eye health ingredients market research report includes in-depth coverage of the industry with estimates & forecast in terms of volume in tons and revenue in USD million from 2013 to 2024, for the following segments:

Eye Health Ingredients Market, By Source

    Natural
    Synthetic

Eye Health Ingredients Market, By Ingredient

    Lutein
    Zeaxanthin
    Beta Carotene
    Vitamin A
    Bilberry Extracts
    Others (Vitamin C, Vitamin E, Zinc & Omega-3 fatty acids, Astaxanthin)

Eye Health Ingredients Market, By Form

    Soft gel, capsule & tablets
    Liquid
    Powder

Eye Health Ingredients Market, By Application

    Human
    Animal

Eye Health Ingredients Market, By Disease Indication

    Age related macular degeneration
    Cataract
    Dry eye syndrome
    Other indications

The above information has been provided on a regional and country basis for the following:

    North America
        U.S.
        Canada
    EU
        Germany
        UK
        France
        Italy
        Spain
        Poland
        Russia
        Netherlands
    Asia Pacific
        China
        India
        Japan
        Australia
        South Korea
        Malaysia
        Indonesia
        Thailand
        Singapore
    Latin America
        Brazil
        Argentina
        Mexico
    Middle East and Africa
        Saudi Arabia
        UAE
        South Africa

Report Content

Chapter 1. Methodology & Scope

1.1. Methodology

1.1.1. Initial data exploration

1.1.2. Statistical model and forecast

1.1.3. Industry insights and validation

1.1.4. Definitions & forecast parameters

1.2. Data sources

1.2.1. Secondary

1.2.2. Primary

Chapter 2. Executive Summary

2.1. Eye health ingredients market 3600 synopsis, 2013 –2024

2.1.1. Business trends

2.1.2. Source trends

2.1.3. Ingredient trends

2.1.4. Form trends

2.1.5. Application trends

2.1.6. Disease indication trends

2.1.7. Regional trends

Chapter 3. Eye Health Ingredients Industry Insights

3.1. Industry segmentation

3.2. Industry growth landscape, 2013 - 2024

3.3. Industry ecosystem analysis

3.3.1. Regional profit margin trends

3.3.1.1. North America

3.3.1.2. Europe

3.3.1.3. APAC

3.3.1.4. LATAM

3.3.1.5. MEA

3.3.2. Vendor matrix

3.3.2.1. Raw material suppliers

3.3.2.2. Ingredient manufacturers

3.3.2.3. Geographical footprint

3.3.2.4. Production capacity of key players

3.3.3. Distribution channel analysis

3.3.3.1. Supermarkets

3.3.3.2. Specialty retail

3.3.3.3. Pharmacy Chains

3.3.3.4. Independent Retailers

3.3.3.5. Internet/ home shopping

3.4. Regional pricing trends

3.4.1.1. North America

3.4.1.2. Europe

3.4.1.3. APAC

3.4.1.4. LATAM

3.4.1.5. MEA

3.5. Trade scenario

3.6. Regulatory landscape

3.6.1. Regulation of Color Additives

3.6.1.1. U.S.

3.6.1.2. Europe

3.6.1.3. China

3.6.1.4. APAC

3.7. Regional raw material trends

3.7.1. Lutein

3.7.2. Zeaxanthin

3.7.3. Beta Carotene

3.7.4. Vitamin A

3.7.5. Bilberry extracts

3.7.6. Others (Capsanthin, Annatto, Omega-3)

3.8. Industry impact forces

3.8.1. Growth drivers

3.8.1.1. Increasing consumer concerns around eye health

3.8.1.2. Nutraceutical industry expansion

3.8.1.3. Increasing AMD disease occurrence among geriatric population

3.8.1.4. Increase in healthcare expenditure leading consumer interest over OTC supplements

3.8.2. Industry pitfalls & challenges

3.8.2.1. Limited availability of lutein and zeaxanthin

3.8.2.2. Harmful health effects from carotenoid consumption

3.9. Eye health ingredients latest product launches

3.9.1. U.S.

3.9.2. Germany

3.9.3. Russia

3.9.4. India

3.9.5. UK

3.9.6. China

3.9.7. Brazil

3.9.8. South Africa

3.10. Growth potential analysis, 2016

3.11. Critical success factors

3.11.1. Role of industry associations

3.11.2. International demographics of declining vision

3.11.3. Consumer behavior towards eye health ingredients

3.11.4. OTC eye care supplements vs prescribed eyecare supplements

3.11.5. Regional consumer insights

3.11.5.1. North America

3.11.5.2. Europe

3.11.5.3. APAC

3.11.5.4. LATAM

3.11.5.5. MEA

3.12. Porter's analysis

3.13. Company market share analysis, 2016

3.13.1. Strategy dashboard

3.14. PESTEL analysis

Chapter 4. Eye Health Ingredients Market, By Source

4.1. Global eye health ingredients market share by source, 2016 & 2024

4.2. Natural

4.2.1. Market estimates and forecast, 2013 - 2024

4.2.2. Market estimates and forecast, by region, 2013–2024

4.3. Synthetic

4.3.1. Market estimates and forecast, 2013 - 2024

4.3.2. Market estimates and forecast, by region, 2013–2024

Chapter 5. Eye Health Ingredients Market, By Ingredient

5.1. Global eye health ingredients market share by ingredient, 2016 & 2024

5.2. Lutein

5.2.1. Market estimates and forecast, 2013 - 2024

5.2.2. Market estimates and forecast, by region, 2013–2024

5.3. Zeaxanthin

5.3.1. Market estimates and forecast, 2013 - 2024

5.3.2. Market estimates and forecast, by region, 2013–2024

5.4. Beta Carotene

5.4.1. Market estimates and forecast, 2013 - 2024

5.4.2. Market estimates and forecast, by region, 2013–2024

5.5. Vitamin A

5.5.1. Market estimates and forecast, 2013 - 2024

5.5.2. Market estimates and forecast, by region, 2013–2024

5.6. Bilberry extracts

5.6.1. Market estimates and forecast, 2013 - 2024

5.6.2. Market estimates and forecast, by region, 2013–2024

5.7. Others (Vitamin C, Vitamin E, Zinc & Omega-3 fatty acids, Astaxanthin)

5.7.1. Market estimates and forecast, 2013 - 2024

5.7.2. Market estimates and forecast, by region, 2013–2024

Chapter 6. Eye Health Ingredients Market, By Form

6.1. Global eye health ingredients market share by form, 2016 & 2024

6.2. Soft gel, capsule & tablets

6.2.1. Market estimates and forecast, 2013 - 2024

6.2.2. Market estimates and forecast, by region, 2013–2024

6.3. Liquid

6.3.1. Market estimates and forecast, 2013 - 2024

6.3.2. Market estimates and forecast, by region, 2013–2024

6.4. Powder

6.4.1. Market estimates and forecast, 2013 - 2024

6.4.2. Market estimates and forecast, by region, 2013–2024

Chapter 7. Eye Health Ingredients Market, By Application

7.1. Global eye health ingredients market share by application, 2016 & 2024

7.2. Human

7.2.1. Market estimates and forecast, 2013 - 2024

7.2.2. Market estimates and forecast, by region, 2013–2024

7.3. Animal

7.3.1. Market estimates and forecast, 2013 - 2024

7.3.2. Market estimates and forecast, by region, 2013–2024

Chapter 8. Eye Health Ingredients Market, By Disease Indication

8.1. Global eye health ingredients market share by disease indication, 2016 & 2024

8.2. Age related macular degeneration

8.2.1. Market estimates and forecast, 2013 - 2024

8.2.2. Market estimates and forecast, by region, 2013–2024

8.3. Cataract

8.3.1. Market estimates and forecast, 2013 - 2024

8.3.2. Market estimates and forecast, by region, 2013–2024

8.4. Dry eye syndrome

8.4.1. Market estimates and forecast, 2013 - 2024

8.4.2. Market estimates and forecast, by region, 2013–2024

8.5. Other indications

8.5.1. Market estimates and forecast, 2013 - 2024

8.5.2. Market estimates and forecast, by region, 2013–2024

Chapter 9. Eye Health Ingredients Market, By Region

9.1. Global eye health ingredients market share by region, 2016 & 2024

9.2. North America

9.2.1. Market estimates and forecast, 2013 – 2024

9.2.2. Market estimates and forecast, by source, 2013 – 2024

9.2.3. Market estimates and forecast, by ingredient, 2013 – 2024

9.2.4. Market estimates and forecast, by form, 2013 – 2024

9.2.5. Market estimates and forecast, by application, 2013 – 2024

9.2.6. Market estimates and forecast, by disease indication, 2013 – 2024

9.2.7. U.S.

9.2.7.1. Market estimates and forecast, 2013 – 2024

9.2.7.2. Market estimates and forecast, by source, 2013 – 2024

9.2.7.3. Market estimates and forecast, by ingredient, 2013 – 2024

9.2.7.4. Market estimates and forecast, by form, 2013 – 2024

9.2.7.5. Market estimates and forecast, by application, 2013 – 2024

9.2.7.6. Market estimates and forecast, by disease indication, 2013 – 2024

9.2.8. Canada

9.2.8.1. Market estimates and forecast, 2013 – 2024

9.2.8.2. Market estimates and forecast, by source, 2013 – 2024

9.2.8.3. Market estimates and forecast, by ingredient, 2013 – 2024

9.2.8.4. Market estimates and forecast, by form, 2013 – 2024

9.2.8.5. Market estimates and forecast, by application, 2013 – 2024

9.2.8.6. Market estimates and forecast, by disease indication, 2013 – 2024

9.3. Europe

9.3.1. Market estimates and forecast, 2013 – 2024

9.3.2. Market estimates and forecast, by source, 2013 – 2024

9.3.3. Market estimates and forecast, by ingredient, 2013 – 2024

9.3.4. Market estimates and forecast, by form, 2013 – 2024

9.3.5. Market estimates and forecast, by application, 2013 – 2024

9.3.6. Market estimates and forecast, by disease indication, 2013 – 2024

9.3.7. Germany

9.3.7.1. Market estimates and forecast, 2013 – 2024

9.3.7.2. Market estimates and forecast, by source, 2013 – 2024

9.3.7.3. Market estimates and forecast, by ingredient, 2013 – 2024

9.3.7.4. Market estimates and forecast, by form, 2013 – 2024

9.3.7.5. Market estimates and forecast, by application, 2013 – 2024

9.3.7.6. Market estimates and forecast, by disease indication, 2013 – 2024

9.3.8. UK

9.3.8.1. Market estimates and forecast, 2013 – 2024

9.3.8.2. Market estimates and forecast, by source, 2013 – 2024

9.3.8.3. Market estimates and forecast, by ingredient, 2013 – 2024

9.3.8.4. Market estimates and forecast, by form, 2013 – 2024

9.3.8.5. Market estimates and forecast, by application, 2013 – 2024

9.3.8.6. Market estimates and forecast, by disease indication, 2013 – 2024

9.3.9. France

9.3.9.1. Market estimates and forecast, 2013 – 2024

9.3.9.2. Market estimates and forecast, by source, 2013 – 2024

9.3.9.3. Market estimates and forecast, by ingredient, 2013 – 2024

9.3.9.4. Market estimates and forecast, by form, 2013 – 2024

9.3.9.5. Market estimates and forecast, by application, 2013 – 2024

9.3.9.6. Market estimates and forecast, by disease indication, 2013 – 2024

9.3.10. Italy

9.3.10.1. Market estimates and forecast, 2013 – 2024

9.3.10.2. Market estimates and forecast, by source, 2013 – 2024

9.3.10.3. Market estimates and forecast, by ingredient, 2013 – 2024

9.3.10.4. Market estimates and forecast, by form, 2013 – 2024

9.3.10.5. Market estimates and forecast, by application, 2013 – 2024

9.3.10.6. Market estimates and forecast, by disease indication, 2013 – 2024

9.3.11. Russia

9.3.11.1. Market estimates and forecast, 2013 – 2024

9.3.11.2. Market estimates and forecast, by source, 2013 – 2024

9.3.11.3. Market estimates and forecast, by ingredient, 2013 – 2024

9.3.11.4. Market estimates and forecast, by form, 2013 – 2024

9.3.11.5. Market estimates and forecast, by application, 2013 – 2024

9.3.11.6. Market estimates and forecast, by disease indication, 2013 – 2024

9.4. Asia Pacific

9.4.1. Market estimates and forecast, 2013 – 2024

9.4.2. Market estimates and forecast, by source, 2013 – 2024

9.4.3. Market estimates and forecast, by ingredient, 2013 – 2024

9.4.4. Market estimates and forecast, by form, 2013 – 2024

9.4.5. Market estimates and forecast, by application, 2013 – 2024

9.4.6. Market estimates and forecast, by disease indication, 2013 – 2024

9.4.7. China

9.4.7.1. Market estimates and forecast, 2013 – 2024

9.4.7.2. Market estimates and forecast, by source, 2013 – 2024

9.4.7.3. Market estimates and forecast, by ingredient, 2013 – 2024

9.4.7.4. Market estimates and forecast, by form, 2013 – 2024

9.4.7.5. Market estimates and forecast, by application, 2013 – 2024

9.4.7.6. Market estimates and forecast, by disease indication, 2013 – 2024

9.4.8. India

9.4.8.1. Market estimates and forecast, 2013 – 2024

9.4.8.2. Market estimates and forecast, by source, 2013 – 2024

9.4.8.3. Market estimates and forecast, by ingredient, 2013 – 2024

9.4.8.4. Market estimates and forecast, by form, 2013 – 2024

9.4.8.5. Market estimates and forecast, by application, 2013 – 2024

9.4.8.6. Market estimates and forecast, by disease indication, 2013 – 2024

9.4.9. South Korea

9.4.9.1. Market estimates and forecast, 2013 – 2024

9.4.9.2. Market estimates and forecast, by source, 2013 – 2024

9.4.9.3. Market estimates and forecast, by ingredient, 2013 – 2024

9.4.9.4. Market estimates and forecast, by form, 2013 – 2024

9.4.9.5. Market estimates and forecast, by application, 2013 – 2024

9.4.9.6. Market estimates and forecast, by disease indication, 2013 – 2024

9.4.10. Japan

9.4.10.1. Market estimates and forecast, 2013 – 2024

9.4.10.2. Market estimates and forecast, by source, 2013 – 2024

9.4.10.3. Market estimates and forecast, by ingredient, 2013 – 2024

9.4.10.4. Market estimates and forecast, by form, 2013 – 2024

9.4.10.5. Market estimates and forecast, by application, 2013 – 2024

9.4.10.6. Market estimates and forecast, by disease indication, 2013 – 2024

9.5. Latin America

9.5.1. Market estimates and forecast, 2013 – 2024

9.5.2. Market estimates and forecast, by source, 2013 – 2024

9.5.3. Market estimates and forecast, by ingredient, 2013 – 2024

9.5.4. Market estimates and forecast, by form, 2013 – 2024

9.5.5. Market estimates and forecast, by application, 2013 – 2024

9.5.6. Market estimates and forecast, by disease indication, 2013 – 2024

9.5.7. Brazil

9.5.7.1. Market estimates and forecast, 2013 – 2024

9.5.7.2. Market estimates and forecast, by source, 2013 – 2024

9.5.7.3. Market estimates and forecast, by ingredient, 2013 – 2024

9.5.7.4. Market estimates and forecast, by form, 2013 – 2024

9.5.7.5. Market estimates and forecast, by application, 2013 – 2024

9.5.7.6. Market estimates and forecast, by disease indication, 2013 – 2024

9.5.8. Mexico

9.5.8.1. Market estimates and forecast, 2013 – 2024

9.5.8.2. Market estimates and forecast, by source, 2013 – 2024

9.5.8.3. Market estimates and forecast, by ingredient, 2013 – 2024

9.5.8.4. Market estimates and forecast, by form, 2013 – 2024

9.5.8.5. Market estimates and forecast, by application, 2013 – 2024

9.5.8.6. Market estimates and forecast, by disease indication, 2013 – 2024

9.5.9. Argentina

9.5.9.1. Market estimates and forecast, 2013 – 2024

9.5.9.2. Market estimates and forecast, by source, 2013 – 2024

9.5.9.3. Market estimates and forecast, by ingredient, 2013 – 2024

9.5.9.4. Market estimates and forecast, by form, 2013 – 2024

9.5.9.5. Market estimates and forecast, by application, 2013 – 2024

9.5.9.6. Market estimates and forecast, by disease indication, 2013 – 2024

9.6. Middle East & Africa (MEA)

9.6.1. Market estimates and forecast, 2013 – 2024

9.6.2. Market estimates and forecast, by source, 2013 – 2024

9.6.3. Market estimates and forecast, by ingredient, 2013 – 2024

9.6.4. Market estimates and forecast, by form, 2013 – 2024

9.6.5. Market estimates and forecast, by application, 2013 – 2024

9.6.6. Market estimates and forecast, by disease indication, 2013 – 2024

9.6.7. Saudi Arabia

9.6.7.1. Market estimates and forecast, 2013 – 2024

9.6.7.2. Market estimates and forecast, by source, 2013 – 2024

9.6.7.3. Market estimates and forecast, by ingredient, 2013 – 2024

9.6.7.4. Market estimates and forecast, by form, 2013 – 2024

9.6.7.5. Market estimates and forecast, by application, 2013 – 2024

9.6.7.6. Market estimates and forecast, by disease indication, 2013 – 2024

9.6.8. UAE

9.6.8.1. Market estimates and forecast, 2013 – 2024

9.6.8.2. Market estimates and forecast, by source, 2013 – 2024

9.6.8.3. Market estimates and forecast, by ingredient, 2013 – 2024

9.6.8.4. Market estimates and forecast, by form, 2013 – 2024

9.6.8.5. Market estimates and forecast, by application, 2013 – 2024

9.6.8.6. Market estimates and forecast, by disease indication, 2013 – 2024

9.6.9. South Africa

9.6.9.1. Market estimates and forecast, 2013 – 2024

9.6.9.2. Market estimates and forecast, by source, 2013 – 2024

9.6.9.3. Market estimates and forecast, by ingredient, 2013 – 2024

9.6.9.4. Market estimates and forecast, by form, 2013 – 2024

9.6.9.5. Market estimates and forecast, by application, 2013 – 2024

9.6.9.6. Market estimates and forecast, by disease indication, 2013 – 2024

Chapter 10. Company Profiles

10.1. Allied Biotech Corporation

10.1.1. Business Overview

10.1.2. Financial Data

10.1.3. Concentrations Landscape

10.1.4. Strategic Outlook

10.1.5. SWOT Analysis

10.2. BASF

10.2.1. Business Overview

10.2.2. Financial Data

10.2.3. Concentrations Landscape

10.2.4. Strategic Outlook

10.2.5. SWOT Analysis

10.3. DSM

10.3.1. Business Overview

10.3.2. Financial Data

10.3.3. Concentrations Landscape

10.3.4. Strategic Outlook

10.3.5. SWOT Analysis

10.4. Kemin

10.4.1. Business Overview

10.4.2. Financial Data

10.4.3. Concentrations Landscape

10.4.4. Strategic Outlook

10.4.5. SWOT Analysis

10.5. Tianjin Pharmaland Technology

10.5.1. Business Overview

10.5.2. Financial Data

10.5.3. Concentrations Landscape

10.5.4. Strategic Outlook

10.5.5. SWOT Analysis

10.6. American River Nutrition, Inc

10.6.1. Business Overview

10.6.2. Financial Data

10.6.3. Concentrations Landscape

10.6.4. Strategic Outlook

10.6.5. SWOT Analysis

10.7. Archer Daniels Midland Company

10.7.1. Business Overview

10.7.2. Financial Data

10.7.3. Concentrations Landscape

10.7.4. Strategic Outlook

10.7.5. SWOT Analysis

10.8. Vitae Naturals

10.8.1. Business Overview

10.8.2. Financial Data

10.8.3. Concentrations Landscape

10.8.4. Strategic Outlook

10.8.5. SWOT Analysis

10.9. Davos life Science

10.9.1. Business Overview

10.9.2. Financial Data

10.9.3. Concentrations Landscape

10.9.4. Strategic Outlook

10.9.5. SWOT Analysis

10.10. Cargil

10.10.1. Business Overview

10.10.2. Financial Data

10.10.3. Concentrations Landscape

10.10.4. Strategic Outlook

10.10.5. SWOT Analysis

10.11. Wilmer Spring Fruit Nutrition Products Co. Ltd

10.11.1. Business Overview

10.11.2. Financial Data

10.11.3. Concentrations Landscape

10.11.4. Strategic Outlook

10.11.5. SWOT Analysis

10.12. FMC corporation

10.12.1. Business Overview

10.12.2. Financial Data

10.12.3. Concentrations Landscape

10.12.4. Strategic Outlook

10.12.5. SWOT Analysis

10.13. Vidya Europe SAS

10.13.1. Business Overview

10.13.2. Financial Data

10.13.3. Concentrations Landscape

10.13.4. Strategic Outlook

10.13.5. SWOT Analysis

Chapter 11. Potential Customer Profiles

11.1. Amway

11.1.1. Business Overview

11.1.2. Financial Data

11.1.3. Concentrations Landscape

11.1.4. Strategic Outlook

11.2. Solgar

11.2.1. Business Overview

11.2.2. Financial Data

11.2.3. Concentrations Landscape

11.2.4. Strategic Outlook

11.3. Life extension

11.3.1. Business Overview

11.3.2. Financial Data

11.3.3. Concentrations Landscape

11.3.4. Strategic Outlook

11.4. Jarrow Formulas

11.4.1. Business Overview

11.4.2. Financial Data

11.4.3. Concentrations Landscape

11.4.4. Strategic Outlook

11.5. NOW Foods

11.5.1. Business Overview

11.5.2. Financial Data

11.5.3. Concentrations Landscape

11.5.4. Strategic Outlook

11.6. Natures’s Life

11.6.1. Business Overview

11.6.2. Financial Data

11.6.3. Concentrations Landscape

11.6.4. Strategic Outlook

11.7. Nutrovea

11.7.1. Business Overview

11.7.2. Financial Data

11.7.3. Concentrations Landscape

11.7.4. Strategic Outlook

11.8. Natures Lab

11.8.1. Business Overview

11.8.2. Financial Data

11.8.3. Concentrations Landscape

11.8.4. Strategic Outlook

11.9. Zenith Nutrition

11.9.1. Business Overview

11.9.2. Financial Data

11.9.3. Concentrations Landscape

11.9.4. Strategic Outlook

11.10. Blubonnet Nutrition

11.10.1. Business Overview

11.10.2. Financial Data

11.10.3. Concentrations Landscape

11.10.4. Strategic Outlook

11.11. Sirulina

11.11.1. Business Overview

11.11.2. Financial Data

11.11.3. Concentrations Landscape

11.11.4. Strategic Outlook

11.12. Caps Extra

11.12.1. Business Overview

11.12.2. Financial Data

11.12.3. Concentrations Landscape

11.12.4. Strategic Outlook

11.13. MacuShield

11.13.1. Business Overview

11.13.2. Financial Data

11.13.3. Concentrations Landscape

11.13.4. Strategic Outlook

11.14. PreserVision

11.14.1. Business Overview

11.14.2. Financial Data

11.14.3. Concentrations Landscape

11.14.4. Strategic Outlook

11.15. Efalex

11.15.1. Business Overview

11.15.2. Financial Data

11.15.3. Concentrations Landscape

11.15.4. Strategic Outlook

11.16. BioCare NutriGuard

11.16.1. Business Overview

11.16.2. Financial Data

11.16.3. Concentrations Landscape

11.16.4. Strategic Outlook

11.17. Futurebiotics

11.17.1. Business Overview

11.17.2. Financial Data

11.17.3. Concentrations Landscape

11.17.4. Strategic Outlook

11.18. Swanson Products

11.18.1. Business Overview

11.18.2. Financial Data

11.18.3. Concentrations Landscape

11.18.4. Strategic Outlook

11.19. Davis Vision

11.19.1. Business Overview

11.19.2. Financial Data

11.19.3. Concentrations Landscape

11.19.4. Strategic Outlook

11.20. Alcon

11.20.1. Business Overview

11.20.2. Financial Data

11.20.3. Concentrations Landscape

11.20.4. Strategic Outlook

11.21. Pfizer Inc.

11.21.1. Business Overview

11.21.2. Financial Data

11.21.3. Concentrations Landscape

11.21.4. Strategic Outlook

11.22. Vitabiotics Ltd.

11.22.1. Business Overview

11.22.2. Financial Data

11.22.3. Concentrations Landscape

11.22.4. Strategic Outlook

11.23. Valeant Pharmaceuticals International Inc.

11.23.1. Business Overview

11.23.2. Financial Data

11.23.3. Concentrations Landscape

11.23.4. Strategic Outlook

11.24. Alliance Pharma

11.24.1. Business Overview

11.24.2. Financial Data

11.24.3. Concentrations Landscape

11.24.4. Strategic Outlook

11.25. The Nature's Bounty Co

11.25.1. Business Overview

11.25.2. Financial Data

11.25.3. Concentrations Landscape

11.25.4. Strategic Outlook

11.26. Novartis AG

11.26.1. Business Overview

11.26.2. Financial Data

11.26.3. Concentrations Landscape

11.26.4. Strategic Outlook



Data Tables

TABLE 1 Eye health ingredients industry 3600 synopsis, 2013 - 2024

TABLE 2 Global eye health ingredients market, 2013 - 2024, (Tons) (Revenue)

TABLE 3 Global market estimates by region, 2013 - 2024 (Tons) (Revenue)

TABLE 4 Global market estimates by source, 2013 - 2024 (Tons) (Revenue)

TABLE 5 Global market estimates by ingredient, 2013 - 2024 (Tons) (Revenue)

TABLE 6 Global market estimates by form, 2013 - 2024 (Tons) (Revenue)

TABLE 7 Global market estimates by application, 2013 - 2024 (Tons) (Revenue)

TABLE 8 Global market estimates by disease indication, 2013 - 2024 (Tons) (Revenue)

TABLE 9 Industry ecosystem analysis

TABLE 10 Growth drivers

TABLE 11 Industry pitfalls & challenges

TABLE 12 Natural eye health ingredients market estimates and forecast, 2013 – 2024, (Tons) (USD Million)

TABLE 13 Natural eye health ingredients market estimates and forecast by region, 2013– 2024, (Tons)

TABLE 14 Natural eye health ingredients market estimates and forecast by region, 2013– 2024, (USD Million)

TABLE 15 Synthetic eye health ingredients market estimates and forecast, 2013 – 2024, (Tons) (USD Million)

TABLE 16 Synthetic eye health ingredients market estimates and forecast by region, 2013– 2024, (Tons)

TABLE 17 Synthetic eye health ingredients market estimates and forecast by region, 2013– 2024, (USD Million)

TABLE 18 Lutein eye health ingredients market estimates and forecast, 2013 – 2024, (Tons) (USD Million)

TABLE 19 Lutein eye health ingredients market estimates and forecast by region, 2013– 2024, (Tons)

TABLE 20 Lutein eye health ingredients market estimates and forecast by region, 2013– 2024, (USD Million)

TABLE 21 Zeaxanthin eye health ingredients market estimates and forecast, 2013 – 2024, (Tons) (USD Million)

TABLE 22 Zeaxanthin eye health ingredients market estimates and forecast by region, 2013– 2024, (Tons)

TABLE 23 Zeaxanthin eye health ingredients market estimates and forecast by region, 2013– 2024, (USD Million)

TABLE 24 Beta Carotene eye health ingredients market estimates and forecast, 2013 – 2024, (Tons) (USD Million)

TABLE 25 Beta Carotene eye health ingredients market estimates and forecast by region, 2013– 2024, (Tons)

TABLE 26 Beta Carotene eye health ingredients market estimates and forecast by region, 2013– 2024, (USD Million)

TABLE 27 Vitamin A eye health ingredients market estimates and forecast, 2013 – 2024, (Tons) (USD Million)

TABLE 28 Vitamin A eye health ingredients market estimates and forecast by region, 2013– 2024, (Tons)

TABLE 29 Vitamin A eye health ingredients market estimates and forecast by region, 2013– 2024, (USD Million)

TABLE 30 Bilberry extracts eye health ingredients market estimates and forecast, 2013 – 2024, (Tons) (USD Million)

TABLE 31 Bilberry extracts eye health ingredients market estimates and forecast by region, 2013– 2024, (Tons)

TABLE 32 Bilberry extracts eye health ingredients market estimates and forecast by region, 2013– 2024, (USD Million)

TABLE 33 Eye health ingredients market estimates and forecast from other products, 2013 – 2024, (Tons) (USD Million)

TABLE 34 Eye health ingredients market estimates and forecast from other ingredients by region, 2013– 2024, (Tons)

TABLE 35 Eye health ingredients market estimates and forecast from other ingredients by region, 2013– 2024, (USD Million)

TABLE 36 Eye health ingredients market estimates and forecast from soft gel, capsule & tablets, 2013 – 2024, (Tons) (USD Million)

TABLE 37 Eye health ingredients market estimates and forecast from soft gel, capsule & tablets by region, 2013– 2024, (Tons)

TABLE 38 Eye health ingredients market estimates and forecast from soft gel, capsule & tablets by region, 2013– 2024, (USD Million)

TABLE 39 Eye health ingredients market estimates and forecast from liquid, 2013 – 2024, (Tons) (USD Million)

TABLE 40 Eye health ingredients market estimates and forecast from liquid by region, 2013– 2024, (Tons)

TABLE 41 Eye health ingredients market estimates and forecast from liquid by region, 2013– 2024, (USD Million)

TABLE 42 Eye health ingredients market estimates and forecast from powder, 2013 – 2024, (Tons) (USD Million)

TABLE 43 Eye health ingredients market estimates and forecast from powder by region, 2013– 2024, (Tons)

TABLE 44 Eye health ingredients market estimates and forecast from powder by region, 2013– 2024, (USD Million)

TABLE 45 Eye health ingredients market estimates and forecast from human, 2013 – 2024, (Tons) (USD Million)

TABLE 46 Eye health ingredients market estimates and forecast from human by region, 2013– 2024, (Tons)

TABLE 47 Eye health ingredients market estimates and forecast from human by region, 2013– 2024, (USD Million)

TABLE 48 Eye health ingredients market estimates and forecast from animal, 2013 – 2024, (Tons) (USD Million)

TABLE 49 Eye health ingredients market estimates and forecast from animal by region, 2013– 2024, (Tons)

TABLE 50 Eye health ingredients market estimates and forecast from animal by region, 2013– 2024, (USD Million)

TABLE 51 Eye health ingredients market estimates and forecast from age related macular degeneration, 2013 – 2024, (Tons) (USD Million)

TABLE 52 Eye health ingredients market estimates and forecast from age related macular degeneration by region, 2013– 2024, (Tons)

TABLE 53 Eye health ingredients market estimates and forecast from age related macular degeneration by region, 2013– 2024, (USD Million)

TABLE 54 Eye health ingredients market estimates and forecast from cataract, 2013 – 2024, (Tons) (USD Million)

TABLE 55 Eye health ingredients market estimates and forecast from cataract by region, 2013– 2024, (Tons)

TABLE 56 Eye health ingredients market estimates and forecast from cataract by region, 2013– 2024, (USD Million)

TABLE 57 Eye health ingredients market estimates and forecast from dry eye syndrome, 2013 – 2024, (Tons) (USD Million)

TABLE 58 Eye health ingredients market estimates and forecast from dry eye syndrome by region, 2013– 2024, (Tons)

TABLE 59 Eye health ingredients market estimates and forecast from dry eye syndrome by region, 2013– 2024, (USD Million)

TABLE 60 Eye health ingredients market estimates and forecast from other indications, 2013 – 2024, (Tons) (USD Million)

TABLE 61 Eye health ingredients market estimates and forecast from other indications by region, 2013– 2024, (Tons)

TABLE 62 Eye health ingredients market estimates and forecast from other indications by region, 2013– 2024, (USD Million)

TABLE 63 North America market estimates & forecast, 2013 – 2024, (Tons) (USD Million)

TABLE 64 North America market volume estimates & forecast, by source, 2013– 2024, (Tons)

TABLE 65 North America market revenue estimates & forecast, by source, 2013– 2024, (USD Million)

TABLE 66 North America market volume estimates & forecast, by ingredient, 2013– 2024, (Tons)

TABLE 67 North America market revenue estimates & forecast, by ingredient, 2013– 2024, (USD Million)

TABLE 68 North America market volume estimates & forecast, by form, 2013– 2024, (Tons)

TABLE 69 North America market revenue estimates & forecast, by form, 2013– 2024, (USD Million)

TABLE 70 North America market volume estimates & forecast, by application, 2013– 2024, (Tons)

TABLE 71 North America market revenue estimates & forecast, by application, 2013– 2024, (USD Million)

TABLE 72 North America market volume estimates & forecast, by disease indication, 2013– 2024, (Tons)

TABLE 73 North America market revenue estimates & forecast, by disease indication, 2013– 2024, (USD Million)

TABLE 74 U.S. market estimates & forecast, 2013 – 2024, (Tons) (USD Million)

TABLE 75 U.S. market volume estimates & forecast, by source, 2013– 2024, (Tons)

TABLE 76 U.S. market revenue estimates & forecast, by source, 2013– 2024, (USD Million)

TABLE 77 U.S. market volume estimates & forecast, by ingredient, 2013– 2024, (Tons)

TABLE 78 U.S. market revenue estimates & forecast, by ingredient, 2013– 2024, (USD Million)

TABLE 79 U.S. market volume estimates & forecast, by form, 2013– 2024, (Tons)

TABLE 80 U.S. market revenue estimates & forecast, by form, 2013– 2024, (USD Million)

TABLE 81 U.S. market volume estimates & forecast, by application, 2013– 2024, (Tons)

TABLE 82 U.S. market revenue estimates & forecast, by application, 2013– 2024, (USD Million)

TABLE 83 U.S. market volume estimates & forecast, by disease indication, 2013– 2024, (Tons)

TABLE 84 U.S. market revenue estimates & forecast, by disease indication, 2013– 2024, (USD Million)

TABLE 85 Canada market estimates & forecast, 2013 – 2024, (Tons) (USD Million)

TABLE 86 Canada market volume estimates & forecast, by source, 2013– 2024, (Tons)

TABLE 87 Canada market revenue estimates & forecast, by source, 2013– 2024, (USD Million)

TABLE 88 Canada market volume estimates & forecast, by ingredient, 2013– 2024, (Tons)

TABLE 89 Canada market revenue estimates & forecast, by ingredient, 2013– 2024, (USD Million)

TABLE 90 Canada market volume estimates & forecast, by form, 2013– 2024, (Tons)

TABLE 91 Canada market revenue estimates & forecast, by form, 2013– 2024, (USD Million)

TABLE 92 Canada market volume estimates & forecast, by application, 2013– 2024, (Tons)

TABLE 93 Canada market revenue estimates & forecast, by application, 2013– 2024, (USD Million)

TABLE 94 Canada market volume estimates & forecast, by disease indication, 2013– 2024, (Tons)

TABLE 95 Canada market revenue estimates & forecast, by disease indication, 2013– 2024, (USD Million)

TABLE 96 Europe market estimates & forecast, 2013 – 2024, (Tons) (USD Million)

TABLE 97 Europe market volume estimates & forecast, by source, 2013– 2024, (Tons)

TABLE 98 Europe market revenue estimates & forecast, by source, 2013– 2024, (USD Million)

TABLE 99 Europe market volume estimates & forecast, by ingredient, 2013– 2024, (Tons)

TABLE 100 Europe market revenue estimates & forecast, by ingredient, 2013– 2024, (USD Million)

TABLE 101 Europe market volume estimates & forecast, by form, 2013– 2024, (Tons)

TABLE 102 Europe market revenue estimates & forecast, by form, 2013– 2024, (USD Million)

TABLE 103 Europe market volume estimates & forecast, by application, 2013– 2024, (Tons)

TABLE 104 Europe market revenue estimates & forecast, by application, 2013– 2024, (USD Million)

TABLE 105 Europe market volume estimates & forecast, by disease indication, 2013– 2024, (Tons)

TABLE 106 Europe market revenue estimates & forecast, by disease indication, 2013– 2024, (USD Million)

TABLE 107 Germany market estimates & forecast, 2013 – 2024, (Tons) (USD Million)

TABLE 108 Germany market volume estimates & forecast, by source, 2013– 2024, (Tons)

TABLE 109 Germany market revenue estimates & forecast, by source, 2013– 2024, (USD Million)

TABLE 110 Germany market volume estimates & forecast, by ingredient, 2013– 2024, (Tons)

TABLE 111 Germany market revenue estimates & forecast, by ingredient, 2013– 2024, (USD Million)

TABLE 112 Germany market volume estimates & forecast, by form, 2013– 2024, (Tons)

TABLE 113 Germany market revenue estimates & forecast, by form, 2013– 2024, (USD Million)

TABLE 114 Germany market volume estimates & forecast, by application, 2013– 2024, (Tons)

TABLE 115 Germany market revenue estimates & forecast, by application, 2013– 2024, (USD Million)

TABLE 116 Germany market volume estimates & forecast, by disease indication, 2013– 2024, (Tons)

TABLE 117 Germany market revenue estimates & forecast, by disease indication, 2013– 2024, (USD Million)

TABLE 118 UK market estimates & forecast, 2013 – 2024, (Tons) (USD Million)

TABLE 119 UK market volume estimates & forecast, by source, 2013– 2024, (Tons)

TABLE 120 UK market revenue estimates & forecast, by source, 2013– 2024, (USD Million)

TABLE 121 UK market volume estimates & forecast, by ingredient, 2013– 2024, (Tons)

TABLE 122 UK market revenue estimates & forecast, by ingredient, 2013– 2024, (USD Million)

TABLE 123 UK market volume estimates & forecast, by form, 2013– 2024, (Tons)

TABLE 124 UK market revenue estimates & forecast, by form, 2013– 2024, (USD Million)

TABLE 125 UK market volume estimates & forecast, by application, 2013– 2024, (Tons)

TABLE 126 UK market revenue estimates & forecast, by application, 2013– 2024, (USD Million)

TABLE 127 UK market volume estimates & forecast, by disease indication, 2013– 2024, (Tons)

TABLE 128 UK market revenue estimates & forecast, by disease indication, 2013– 2024, (USD Million)

TABLE 129 France market estimates & forecast, 2013 – 2024, (Tons) (USD Million)

TABLE 130 France market volume estimates & forecast, by source, 2013– 2024, (Tons)

TABLE 131 France market revenue estimates & forecast, by source, 2013– 2024, (USD Million)

TABLE 132 France market volume estimates & forecast, by ingredient, 2013– 2024, (Tons)

TABLE 133 France market revenue estimates & forecast, by ingredient, 2013– 2024, (USD Million)

TABLE 134 France market volume estimates & forecast, by form, 2013– 2024, (Tons)

TABLE 135 France market revenue estimates & forecast, by form, 2013– 2024, (USD Million)

TABLE 136 France market volume estimates & forecast, by application, 2013– 2024, (Tons)

TABLE 137 France market revenue estimates & forecast, by application, 2013– 2024, (USD Million)

TABLE 138 France market volume estimates & forecast, by disease indication, 2013– 2024, (Tons)

TABLE 139 France market revenue estimates & forecast, by disease indication, 2013– 2024, (USD Million)

TABLE 140 Poland market estimates & forecast, 2013 – 2024, (Tons) (USD Million)

TABLE 141 Poland market volume estimates & forecast, by source, 2013– 2024, (Tons)

TABLE 142 Poland market revenue estimates & forecast, by source, 2013– 2024, (USD Million)

TABLE 143 Poland market volume estimates & forecast, by ingredient, 2013– 2024, (Tons)

TABLE 144 Poland market revenue estimates & forecast, by ingredient, 2013– 2024, (USD Million)

TABLE 145 Poland market volume estimates & forecast, by form, 2013– 2024, (Tons)

TABLE 146 Poland market revenue estimates & forecast, by form, 2013– 2024, (USD Million)

TABLE 147 Poland market volume estimates & forecast, by application, 2013– 2024, (Tons)

TABLE 148 Poland market revenue estimates & forecast, by application, 2013– 2024, (USD Million)

TABLE 149 Poland market volume estimates & forecast, by disease indication, 2013– 2024, (Tons)

TABLE 150 Poland market revenue estimates & forecast, by disease indication, 2013– 2024, (USD Million)

TABLE 151 Russia market estimates & forecast, 2013 – 2024, (Tons) (USD Million)

TABLE 152 Russia market volume estimates & forecast, by source, 2013– 2024, (Tons)

TABLE 153 Russia market revenue estimates & forecast, by source, 2013– 2024, (USD Million)

TABLE 154 Russia market volume estimates & forecast, by ingredient, 2013– 2024, (Tons)

TABLE 155 Russia market revenue estimates & forecast, by ingredient, 2013– 2024, (USD Million)

TABLE 156 Russia market volume estimates & forecast, by form, 2013– 2024, (Tons)

TABLE 157 Russia market revenue estimates & forecast, by form, 2013– 2024, (USD Million)

TABLE 158 Russia market volume estimates & forecast, by application, 2013– 2024, (Tons)

TABLE 159 Russia market revenue estimates & forecast, by application, 2013– 2024, (USD Million)

TABLE 160 Russia market volume estimates & forecast, by disease indication, 2013– 2024, (Tons)

TABLE 161 Russia market revenue estimates & forecast, by disease indication, 2013– 2024, (USD Million)

TABLE 162 Asia Pacific market estimates & forecast, 2013 – 2024, (Tons) (USD Million)

TABLE 163 Asia Pacific market volume estimates & forecast, by source, 2013– 2024, (Tons)

TABLE 164 Asia Pacific market revenue estimates & forecast, by source, 2013– 2024, (USD Million)

TABLE 165 Asia Pacific market volume estimates & forecast, by ingredient, 2013– 2024, (Tons)

TABLE 166 Asia Pacific market revenue estimates & forecast, by ingredient, 2013– 2024, (USD Million)

TABLE 167 Asia Pacific market volume estimates & forecast, by form, 2013– 2024, (Tons)

TABLE 168 Asia Pacific market revenue estimates & forecast, by form, 2013– 2024, (USD Million)

TABLE 169 Asia Pacific market volume estimates & forecast, by application, 2013– 2024, (Tons)

TABLE 170 Asia Pacific market revenue estimates & forecast, by application, 2013– 2024, (USD Million)

TABLE 171 Asia Pacific market volume estimates & forecast, by disease indication, 2013– 2024, (Tons)

TABLE 172 Asia Pacific market revenue estimates & forecast, by disease indication, 2013– 2024, (USD Million)

TABLE 173 China market estimates & forecast, 2013 – 2024, (Tons) (USD Million)

TABLE 174 China market volume estimates & forecast, by source, 2013– 2024, (Tons)

TABLE 175 China market revenue estimates & forecast, by source, 2013– 2024, (USD Million)

TABLE 176 China market volume estimates & forecast, by ingredient, 2013– 2024, (Tons)

TABLE 177 China market revenue estimates & forecast, by ingredient, 2013– 2024, (USD Million)

TABLE 178 China market volume estimates & forecast, by form, 2013– 2024, (Tons)

TABLE 179 China market revenue estimates & forecast, by form, 2013– 2024, (USD Million)

TABLE 180 China market volume estimates & forecast, by application, 2013– 2024, (Tons)

TABLE 181 China market revenue estimates & forecast, by application, 2013– 2024, (USD Million)

TABLE 182 China market volume estimates & forecast, by disease indication, 2013– 2024, (Tons)

TABLE 183 China market revenue estimates & forecast, by disease indication, 2013– 2024, (USD Million)

TABLE 184 India market estimates & forecast, 2013 – 2024, (Tons) (USD Million)

TABLE 185 India market volume estimates & forecast, by source, 2013– 2024, (Tons)

TABLE 186 India market revenue estimates & forecast, by source, 2013– 2024, (USD Million)

TABLE 187 India market volume estimates & forecast, by ingredient, 2013– 2024, (Tons)

TABLE 188 India market revenue estimates & forecast, by ingredient, 2013– 2024, (USD Million)

TABLE 189 India market volume estimates & forecast, by form, 2013– 2024, (Tons)

TABLE 190 India market revenue estimates & forecast, by form, 2013– 2024, (USD Million)

TABLE 191 India market volume estimates & forecast, by application, 2013– 2024, (Tons)

TABLE 192 India market revenue estimates & forecast, by application, 2013– 2024, (USD Million)

TABLE 193 India market volume estimates & forecast, by disease indication, 2013– 2024, (Tons)

TABLE 194 India market revenue estimates & forecast, by disease indication, 2013– 2024, (USD Million)

TABLE 195 Japan market estimates & forecast, 2013 – 2024, (Tons) (USD Million)

TABLE 196 Japan market volume estimates & forecast, by source, 2013– 2024, (Tons)

TABLE 197 Japan market revenue estimates & forecast, by source, 2013– 2024, (USD Million)

TABLE 198 Japan market volume estimates & forecast, by ingredient, 2013– 2024, (Tons)

TABLE 199 Japan market revenue estimates & forecast, by ingredient, 2013– 2024, (USD Million)

TABLE 200 Japan market volume estimates & forecast, by form, 2013– 2024, (Tons)

TABLE 201 Japan market revenue estimates & forecast, by form, 2013– 2024, (USD Million)

TABLE 202 Japan market volume estimates & forecast, by application, 2013– 2024, (Tons)

TABLE 203 Japan market revenue estimates & forecast, by application, 2013– 2024, (USD Million)

TABLE 204 Japan market volume estimates & forecast, by disease indication, 2013– 2024, (Tons)

TABLE 205 Japan market revenue estimates & forecast, by disease indication, 2013– 2024, (USD Million)

TABLE 206 Indonesia market estimates & forecast, 2013 – 2024, (Tons) (USD Million)

TABLE 207 Indonesia market volume estimates & forecast, by source, 2013– 2024, (Tons)

TABLE 208 Indonesia market revenue estimates & forecast, by source, 2013– 2024, (USD Million)

TABLE 209 Indonesia market volume estimates & forecast, by ingredient, 2013– 2024, (Tons)

TABLE 210 Indonesia market revenue estimates & forecast, by ingredient, 2013– 2024, (USD Million)

TABLE 211 Indonesia market volume estimates & forecast, by form, 2013– 2024, (Tons)

TABLE 212 Indonesia market revenue estimates & forecast, by form, 2013– 2024, (USD Million)

TABLE 213 Indonesia market volume estimates & forecast, by application, 2013– 2024, (Tons)

TABLE 214 Indonesia market revenue estimates & forecast, by application, 2013– 2024, (USD Million)

TABLE 215 Indonesia market volume estimates & forecast, by disease indication, 2013– 2024, (Tons)

TABLE 216 Indonesia market revenue estimates & forecast, by disease indication, 2013– 2024, (USD Million)

TABLE 217 Thailand market estimates & forecast, 2013 – 2024, (Tons) (USD Million)

TABLE 218 Thailand market volume estimates & forecast, by source, 2013– 2024, (Tons)

TABLE 219 Thailand market revenue estimates & forecast, by source, 2013– 2024, (USD Million)

TABLE 220 Thailand market volume estimates & forecast, by ingredient, 2013– 2024, (Tons)

TABLE 221 Thailand market revenue estimates & forecast, by ingredient, 2013– 2024, (USD Million)

TABLE 222 Thailand market volume estimates & forecast, by form, 2013– 2024, (Tons)

TABLE 223 Thailand market revenue estimates & forecast, by form, 2013– 2024, (USD Million)

TABLE 224 Thailand market volume estimates & forecast, by application, 2013– 2024, (Tons)

TABLE 225 Thailand market revenue estimates & forecast, by application, 2013– 2024, (USD Million)

TABLE 226 Thailand market volume estimates & forecast, by disease indication, 2013– 2024, (Tons)

TABLE 227 Thailand market revenue estimates & forecast, by disease indication, 2013– 2024, (USD Million)

TABLE 228 Latin America market estimates & forecast, 2013 – 2024, (Tons) (USD Million)

TABLE 229 Latin America market volume estimates & forecast, by source, 2013– 2024, (Tons)

TABLE 230 Latin America market revenue estimates & forecast, by source, 2013– 2024, (USD Million)

TABLE 231 Latin America market volume estimates & forecast, by ingredient, 2013– 2024, (Tons)

TABLE 232 Latin America market revenue estimates & forecast, by ingredient, 2013– 2024, (USD Million)

TABLE 233 Latin America market volume estimates & forecast, by form, 2013– 2024, (Tons)

TABLE 234 Latin America market revenue estimates & forecast, by form, 2013– 2024, (USD Million)

TABLE 235 Latin America market volume estimates & forecast, by application, 2013– 2024, (Tons)

TABLE 236 Latin America market revenue estimates & forecast, by application, 2013– 2024, (USD Million)

TABLE 237 Latin America market volume estimates & forecast, by disease indication, 2013– 2024, (Tons)

TABLE 238 Latin America market revenue estimates & forecast, by disease indication, 2013– 2024, (USD Million)

TABLE 239 Brazil market estimates & forecast, 2013 – 2024, (Tons) (USD Million)

TABLE 240 Brazil market volume estimates & forecast, by source, 2013– 2024, (Tons)

TABLE 241 Brazil market revenue estimates & forecast, by source, 2013– 2024, (USD Million)

TABLE 242 Brazil market volume estimates & forecast, by ingredient, 2013– 2024, (Tons)

TABLE 243 Brazil market revenue estimates & forecast, by ingredient, 2013– 2024, (USD Million)

TABLE 244 Brazil market volume estimates & forecast, by form, 2013– 2024, (Tons)

TABLE 245 Brazil market revenue estimates & forecast, by form, 2013– 2024, (USD Million)

TABLE 246 Brazil market volume estimates & forecast, by application, 2013– 2024, (Tons)

TABLE 247 Brazil market revenue estimates & forecast, by application, 2013– 2024, (USD Million)

TABLE 248 Brazil market volume estimates & forecast, by disease indication, 2013– 2024, (Tons)

TABLE 249 Brazil market revenue estimates & forecast, by disease indication, 2013– 2024, (USD Million)

TABLE 250 Mexico market estimates & forecast, 2013 – 2024, (Tons) (USD Million)

TABLE 251 Mexico market volume estimates & forecast, by source, 2013– 2024, (Tons)

TABLE 252 Mexico market revenue estimates & forecast, by source, 2013– 2024, (USD Million)

TABLE 253 Mexico market volume estimates & forecast, by ingredient, 2013– 2024, (Tons)

TABLE 254 Mexico market revenue estimates & forecast, by ingredient, 2013– 2024, (USD Million)

TABLE 255 Mexico market volume estimates & forecast, by form, 2013– 2024, (Tons)

TABLE 256 Mexico market revenue estimates & forecast, by form, 2013– 2024, (USD Million)

TABLE 257 Mexico market volume estimates & forecast, by application, 2013– 2024, (Tons)

TABLE 258 Mexico market revenue estimates & forecast, by application, 2013– 2024, (USD Million)

TABLE 259 Mexico market volume estimates & forecast, by disease indication, 2013– 2024, (Tons)

TABLE 260 Mexico market revenue estimates & forecast, by disease indication, 2013– 2024, (USD Million)

TABLE 261 Argentina market estimates & forecast, 2013 – 2024, (Tons) (USD Million)

TABLE 262 Argentina market volume estimates & forecast, by source, 2013– 2024, (Tons)

TABLE 263 Argentina market revenue estimates & forecast, by source, 2013– 2024, (USD Million)

TABLE 264 Argentina market volume estimates & forecast, by ingredient, 2013– 2024, (Tons)

TABLE 265 Argentina market revenue estimates & forecast, by ingredient, 2013– 2024, (USD Million)

TABLE 266 Argentina market volume estimates & forecast, by form, 2013– 2024, (Tons)

TABLE 267 Argentina market revenue estimates & forecast, by form, 2013– 2024, (USD Million)

TABLE 268 Argentina market volume estimates & forecast, by application, 2013– 2024, (Tons)

TABLE 269 Argentina market revenue estimates & forecast, by application, 2013– 2024, (USD Million)

TABLE 270 Argentina market volume estimates & forecast, by disease indication, 2013– 2024, (Tons)

TABLE 271 Argentina market revenue estimates & forecast, by disease indication, 2013– 2024, (USD Million)

TABLE 272 Middle East & Africa market estimates & forecast, 2013 – 2024, (Tons) (USD Million)

TABLE 273 Middle East & Africa market volume estimates & forecast, by source, 2013– 2024, (Tons)

TABLE 274 Middle East & Africa market revenue estimates & forecast, by source, 2013– 2024, (USD Million)

TABLE 275 Middle East & Africa market volume estimates & forecast, by ingredient, 2013– 2024, (Tons)

TABLE 276 Middle East & Africa market revenue estimates & forecast, by ingredient, 2013– 2024, (USD Million)

TABLE 277 Middle East & Africa market volume estimates & forecast, by form, 2013– 2024, (Tons)

TABLE 278 Middle East & Africa market revenue estimates & forecast, by form, 2013– 2024, (USD Million)

TABLE 279 Middle East & Africa market volume estimates & forecast, by application, 2013– 2024, (Tons)

TABLE 280 Middle East & Africa market revenue estimates & forecast, by application, 2013– 2024, (USD Million)

TABLE 281 Middle East & Africa market volume estimates & forecast, by disease indication, 2013– 2024, (Tons)

TABLE 282 Middle East & Africa market revenue estimates & forecast, by disease indication, 2013– 2024, (USD Million)

TABLE 283 Saudi Arabia market estimates & forecast, 2013 – 2024, (Tons) (USD Million)

TABLE 284 Saudi Arabia market volume estimates & forecast, by source, 2013– 2024, (Tons)

TABLE 285 Saudi Arabia market revenue estimates & forecast, by source, 2013– 2024, (USD Million)

TABLE 286 Saudi Arabia market volume estimates & forecast, by ingredient, 2013– 2024, (Tons)

TABLE 287 Saudi Arabia market revenue estimates & forecast, by ingredient, 2013– 2024, (USD Million)

TABLE 288 Saudi Arabia market volume estimates & forecast, by form, 2013– 2024, (Tons)

TABLE 289 Saudi Arabia market revenue estimates & forecast, by form, 2013– 2024, (USD Million)

TABLE 290 Saudi Arabia market volume estimates & forecast, by application, 2013– 2024, (Tons)

TABLE 291 Saudi Arabia market revenue estimates & forecast, by application, 2013– 2024, (USD Million)

TABLE 292 Saudi Arabia market volume estimates & forecast, by disease indication, 2013– 2024, (Tons)

TABLE 293 Saudi Arabia market revenue estimates & forecast, by disease indication, 2013– 2024, (USD Million)

TABLE 294 UAE market estimates & forecast, 2013 – 2024, (Tons) (USD Million)

TABLE 295 UAE market volume estimates & forecast, by source, 2013– 2024, (Tons)

TABLE 296 UAE market revenue estimates & forecast, by source, 2013– 2024, (USD Million)

TABLE 297 UAE market volume estimates & forecast, by ingredient, 2013– 2024, (Tons)

TABLE 298 UAE market revenue estimates & forecast, by ingredient, 2013– 2024, (USD Million)

TABLE 299 UAE market volume estimates & forecast, by form, 2013– 2024, (Tons)

TABLE 300 UAE market revenue estimates & forecast, by form, 2013– 2024, (USD Million)

TABLE 301 UAE market volume estimates & forecast, by application, 2013– 2024, (Tons)

TABLE 302 UAE market revenue estimates & forecast, by application, 2013– 2024, (USD Million)

TABLE 303 UAE market volume estimates & forecast, by disease indication, 2013– 2024, (Tons)

TABLE 304 UAE market revenue estimates & forecast, by disease indication, 2013– 2024, (USD Million)

TABLE 305 South Africa market estimates & forecast, 2013 – 2024, (Tons) (USD Million)

TABLE 306 South Africa market volume estimates & forecast, by source, 2013– 2024, (Tons)

TABLE 307 South Africa market revenue estimates & forecast, by source, 2013– 2024, (USD Million)

TABLE 308 South Africa market volume estimates & forecast, by ingredient, 2013– 2024, (Tons)

TABLE 309 South Africa market revenue estimates & forecast, by ingredient, 2013– 2024, (USD Million)

TABLE 310 South Africa market volume estimates & forecast, by form, 2013– 2024, (Tons)

TABLE 311 South Africa market revenue estimates & forecast, by form, 2013– 2024, (USD Million)

TABLE 312 South Africa market volume estimates & forecast, by application, 2013– 2024, (Tons)

TABLE 313 South Africa market revenue estimates & forecast, by application, 2013– 2024, (USD Million)

TABLE 314 South Africa market volume estimates & forecast, by disease indication, 2013– 2024, (Tons)

TABLE 315 South Africa market revenue estimates & forecast, by disease indication, 2013– 2024, (USD Million)

Charts & Figures

FIG. 1 Industry segmentation

FIG. 2 Global eye health ingredients market, 2013 - 2024 (USD Million)

FIG. 3 Industry ecosystem analysis

FIG. 4 Industry impact forces

FIG. 5 Growth potential analysis

FIG. 6 Competitive landscape, 2016

FIG. 7 Porter’s analysis

FIG. 8 PESTEL analysis

FIG. 9 Global eye health ingredients market share by source, 2016 & 2024

FIG. 10 Global eye health ingredients market share by ingredient, 2016 & 2024

FIG. 11 Global eye health ingredients market share by form, 2016 & 2024

FIG. 12 Global eye health ingredients market share by end-use, 2016 & 2024

FIG. 13 Global eye health ingredients market share by disease indication, 2016 & 2024

FIG. 14 Global eye health ingredients market share by region, 2016 & 2024


Name*
Email ID*
Company*
Phone (With Country Code)*
What is/are your question(s)?:

Other Reports by Global Market Insights, Inc.

U.S. Direct-to-Consumer Genetic Testing Market Size By Test Type (Carrier Testing, Predictive Testing, Ancestry & Relationship Testing, Nutrigenomics Testing), By Technology (Targeted Analysis, Single Nucleotide Polymorphism (SNP) Chips, Whole Genome Sequencing (WGS)), Industry Analysis Report, Application Potential, Competitive Market Share & Forecast, 2019 - 2025

U.S. Direct-To-Consumer Genetic Testing Market is expected to exceed USD 850 million by 2025. Increasing public awareness pertaining to availability of DTC genetic testing kits will be a high impact rendering factor for the U.S. DTC genetic testing m...

New Food and Beverages Reports

Publisher: Global Market Insights, Inc. 300 Pages   |  329 Tables